Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Civilization Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Civilization Ventures

Civilization Ventures

Operating

Civilization Ventures LLC: A California-based venture capital firm specializing in health tech and biology innovations.

Location
San Francisco, CA, US
Founded
2017
Firm
Compare
Portfolio
Employees
News
Website

Investments

Aperiam Bio
Aperiam Bio

Total Raised

$12.7M

Rounds

2

Seed$9MNovember 2023
DermBiont
DermBiont

Total Raised

$108.5M

Rounds

9

Series B$35.2MOctober 2023
Series A$28MDecember 2021
Range Biotechnologies
Range Biotechnologies

Total Raised

$5.2M

Rounds

2

Seed$5.2MJune 2023
Siren Biotechnology
Siren Biotechnology

Total Raised

$4M

Rounds

2

SeedMay 2023
Foresight Diagnostics
Foresight Diagnostics

Total Raised

$71.3M

Rounds

4

Series B$58.8MApril 2023
Series A$12.5MJune 2021
Sensible Biotechnologies
Sensible Biotechnologies
Pre-Seed

Total Raised

$4.3M

Rounds

3

Pre-Seed$4.2MApril 2023
Outpace Bio
Outpace Bio

Total Raised

$55M

Rounds

2

Series A$25MMarch 2023
Series A$30MMarch 2021
Wyndly
Wyndly
Seed

Total Raised

$2.1M

Rounds

2

Seed$2MFebruary 2023
Infinimmune
Infinimmune

Total Raised

$12M

Rounds

1

Seed$12MDecember 2022
Kernal Biologics
Kernal Biologics
Series A

Total Raised

$25.1M

Rounds

5

Series A$25MJuly 2022
BillionToOne
BillionToOne
Debt

Total Raised

$295.9M

Rounds

7

Series C$125MMarch 2022
Series A$15MMarch 2020
Omada Health
Omada Health

Total Raised

$528.5M

Rounds

11

Series E$192MFebruary 2022
Series D$73MJune 2019
Teiko.bio
Teiko.bio

Total Raised

$11.6M

Rounds

3

Series A$11.6MOctober 2021
Axonis Therapeutics
Axonis Therapeutics

Total Raised

$14.5M

Rounds

10

Series Unknown$5MJuly 2021
Glyphic Biotechnologies
Glyphic Biotechnologies

Total Raised

$10.6M

Rounds

10

Seed$6MJuly 2021
Catena Biosciences
Catena Biosciences

Total Raised

$5.7M

Rounds

2

Pre-Seed$700kApril 2021
adyn
adyn

Total Raised

$2.6M

Rounds

2

Seed$2.5MApril 2021
uLab Systems
uLab Systems
Late Stage Private

Total Raised

$194.4M

Rounds

8

Series E$54.5MApril 2021
R-Zero
R-Zero

Total Raised

$170M

Rounds

6

Series A$15MSeptember 2020
Fluent BioSciences
Fluent BioSciences

Total Raised

$22.9M

Rounds

6

Series A$19.3MJanuary 2020